Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (42) 42
humans (38) 38
male (29) 29
female (26) 26
oncology (25) 25
aged (20) 20
middle aged (19) 19
adult (14) 14
treatment outcome (11) 11
obstetrics & gynecology (8) 8
abridged index medicus (7) 7
animals (7) 7
italy (7) 7
obstetrics and gynecology (7) 7
time factors (7) 7
antineoplastic combined chemotherapy protocols - therapeutic use (6) 6
cancer (6) 6
disease-free survival (6) 6
drug therapy (6) 6
kaplan-meier estimate (6) 6
life sciences (6) 6
soil science (6) 6
therapy (6) 6
adolescent (5) 5
antineoplastic combined chemotherapy protocols - adverse effects (5) 5
bortezomib (5) 5
chemotherapy (5) 5
child (5) 5
elderly-patients (5) 5
medicine, general & internal (5) 5
multiple myeloma - drug therapy (5) 5
research (5) 5
retrospective studies (5) 5
thalidomide - administration & dosage (5) 5
young adult (5) 5
administration, oral (4) 4
aged, 80 and over (4) 4
care and treatment (4) 4
children (4) 4
genetics & heredity (4) 4
health aspects (4) 4
hematology, oncology and palliative medicine (4) 4
internal medicine (4) 4
italy - epidemiology (4) 4
mortality (4) 4
oxidation (4) 4
pharmacology & pharmacy (4) 4
pregnancy (4) 4
risk (4) 4
stem-cell transplantation (4) 4
urology (4) 4
alkyl and aryl transferases - antagonists & inhibitors (3) 3
analysis (3) 3
anticardiolipin antibodies (3) 3
anticoagulants - administration & dosage (3) 3
anticoagulants - therapeutic use (3) 3
anticonvulsants - therapeutic use (3) 3
antineoplastic agents - therapeutic use (3) 3
autolysosome (3) 3
automation (3) 3
biochemistry & molecular biology (3) 3
bladder-cancer (3) 3
boronic acids - administration & dosage (3) 3
cerebrospinal fluid (3) 3
chemotherapy, adjuvant (3) 3
clinical neurology (3) 3
complications and side effects (3) 3
cytofluorimeter (3) 3
dexamethasone - administration & dosage (3) 3
dosage and administration (3) 3
epilepsy (3) 3
farnesyltranstransferase (3) 3
flux (3) 3
follow-up studies (3) 3
hematology (3) 3
ilae commission (3) 3
infant, newborn (3) 3
iron (3) 3
lysosome (3) 3
macroautophagy (3) 3
medicine & public health (3) 3
meningitis (3) 3
multiple myeloma - surgery (3) 3
mutation (3) 3
neurosciences (3) 3
oral anticoagulation (3) 3
patients (3) 3
phagophore (3) 3
pharmacology/toxicology (3) 3
positron emission tomography (3) 3
prospective studies (3) 3
pyrazines - administration & dosage (3) 3
pyrimidines - therapeutic use (3) 3
remission induction (3) 3
side effects (3) 3
soil science & conservation (3) 3
statistics (3) 3
stress (3) 3
studies (3) 3
transplantation, autologous (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study
by Cavo, Michele, Prof and Tacchetti, Paola, MD and Patriarca, Francesca, MD and Petrucci, Maria Teresa, MD and Pantani, Lucia, MD and Galli, Monica, MD and Di Raimondo, Francesco, Prof and Crippa, Claudia, MD and Zamagni, Elena, MD and Palumbo, Antonio, MD and Offidani, Massimo, MD and Corradini, Paolo, Prof and Narni, Franco, MD and Spadano, Antonio, MD and Pescosta, Norbert, MD and Deliliers, Giorgio Lambertenghi, Prof and Ledda, Antonio, MD and Cellini, Claudia, MD and Caravita, Tommaso, MD and Tosi, Patrizia, MD and Baccarani, Michele, Prof and GIMEMA Italian Myeloma Network
Lancet, The, ISSN 0140-6736, 2010, Volume 376, Issue 9758, pp. 2075 - 2085
Summary Background Thalidomide plus dexamethasone (TD) is a standard induction therapy for myeloma. We aimed to assess the efficacy and safety of addition of... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | PREDNISONE | CLINICAL-TRIAL | COMBINATION THERAPY | HERPES-ZOSTER | VTD | HIGH-DOSE MELPHALAN | ELDERLY-PATIENTS | III TRIAL | CHEMOTHERAPY | Humans | Middle Aged | Pyrazines - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Boronic Acids - adverse effects | Dexamethasone - adverse effects | Male | Transplantation, Autologous | Multiple Myeloma - drug therapy | Adult | Female | Boronic Acids - administration & dosage | Chemotherapy, Adjuvant | Multiple Myeloma - surgery | Thalidomide - adverse effects | Reoperation | Bortezomib | Dexamethasone - administration & dosage | Drug Administration Schedule | Multiple Myeloma - diagnosis | Kaplan-Meier Estimate | Hematopoietic Stem Cell Transplantation | Treatment Outcome | Thalidomide - administration & dosage | Remission Induction | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoadjuvant Therapy - methods | Pyrazines - adverse effects | Italy | Aged | Complications and side effects | Dexamethasone | Multiple myeloma | Dosage and administration | Drug therapy | Thalidomide | Studies | Heart failure | Consolidation | Heart attacks | Data collection | Clinical medicine | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Pazopanib in advanced and platinum-resistant urothelial cancer: an open-label, single group, phase 2 trial
by Necchi, Andrea, Dr and Mariani, Luigi, MD and Zaffaroni, Nadia, PhD and Schwartz, Lawrence H, MD and Giannatempo, Patrizia, MD and Crippa, Flavio, MD and Morosi, Carlo, MD and Lanocita, Rodolfo, MD and Sava, Teodoro, MD and Ortega, Cinzia, MD and Messina, Caterina, MD and Sacco, Cosimo, MD and Pennati, Marzia, PhD and Daidone, Maria G, PhD and Nicolai, Nicola, MD and De Braud, Filippo, MD and Gianni, Alessandro M, Prof and Salvioni, Roberto, MD
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 8, pp. 810 - 816
Summary Background The development of new drugs for patients with refractory urothelial cancer is still an unmet medical need. Preclinical evidence lends... 
Hematology, Oncology and Palliative Medicine | BLADDER-CANCER | PROGNOSTIC-FACTORS | ANGIOGENESIS | CISPLATIN | ONCOLOGY | TRANSITIONAL-CELL CARCINOMA | SUNITINIB | RANDOMIZED-TRIAL | INTERLEUKIN-8 | CHEMOTHERAPY | LONG-TERM-SURVIVAL | Humans | Middle Aged | Drug Resistance, Neoplasm | Male | Antineoplastic Agents - therapeutic use | Urothelium - pathology | Urologic Neoplasms - pathology | Angiogenesis Inhibitors - administration & dosage | Urologic Neoplasms - drug therapy | Time Factors | Angiogenesis Inhibitors - therapeutic use | Female | Angiogenesis Inhibitors - adverse effects | Risk Assessment | Administration, Oral | Pyrimidines - administration & dosage | Urologic Neoplasms - mortality | Risk Factors | Kaplan-Meier Estimate | Neoplasm Recurrence, Local | Proportional Hazards Models | Linear Models | Treatment Outcome | Tumor Burden | Disease-Free Survival | Cisplatin - therapeutic use | Sulfonamides - therapeutic use | Pyrimidines - therapeutic use | Pyrimidines - adverse effects | Sulfonamides - adverse effects | Italy | Aged | Urothelium - drug effects | Sulfonamides - administration & dosage | Care and treatment | Endothelial growth factors | Oncology, Experimental | Research | Angiogenesis inhibitors | Vascular endothelial growth factor | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Pattern of pore water nutrients in planted and non-planted soilless substrates as affected by the addition of biochars from wood gasification
by Bedussi, Floriana and Zaccheo, Patrizia and Crippa, Laura
Biology and Fertility of Soils, ISSN 0178-2762, 7/2015, Volume 51, Issue 5, pp. 625 - 635
The primary objective of this study was to evaluate the effects of partial replacement of peat by hardwood (poplar) or softwood (spruce) gasification biochars... 
Life Sciences | NH 4 + -N | NO 3 – -N | Pore water | Agriculture | Biochar | Peat | Potassium | Soil Science & Conservation | NO | NH | N | PYROLYSIS TEMPERATURE | ENERGY-PRODUCTION | CARBON | SORPTION | BIOAVAILABILITY | SOIL SCIENCE | NITRIFICATION | BIOMASS | NO3--N | NITROGEN | DYNAMICS | MEDIA | NH4+-N | Water | Organic fertilizers | Ammonia | Studies | Nutrients | Peatlands
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Major Tumor Shrinking and Persistent Molecular Remissions After Consolidation With Bortezomib, Thalidomide, and Dexamethasone in Patients With Autografted Myeloma
by Marco Ladetto and Gloria Pagliano and Simone Ferrero and Federica Cavallo and Daniela Drandi and Loredana Santo and Claudia Crippa and Luca De Rosa and Patrizia Pregno and Mariella Grasso and Anna Marina Liberati and Tommaso Caravita and Francesco Pisani and Tommasina Guglielmelli and Vincenzo Callea and Pellegrino Musto and Clotilde Cangialosi and Roberto Passera and Mario Boccadoro and Antonio Palumbo
Journal of Clinical Oncology, ISSN 0732-183X, 04/2010, Volume 28, Issue 12, pp. 2077 - 2084
Purpose We investigated the effect on minimal residual disease, by qualitative and real-time quantitative polymerase chain reaction (RQ-PCR), of a... 
REAL-TIME PCR | HEMATOPOIETIC-CELLS | POLYMERASE-CHAIN-REACTION | ONCOLOGY | FREE SURVIVAL | BONE-MARROW | AUTOLOGOUS TRANSPLANTATION | RELAPSED MULTIPLE-MYELOMA | DRUG-RESISTANCE | STEM-CELL TRANSPLANTATION | MINIMAL RESIDUAL DISEASE | Humans | Middle Aged | Pyrazines - administration & dosage | Gene Expression Regulation, Neoplastic | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Transplantation, Autologous | Genes, Immunoglobulin Heavy Chain | Neoplasm, Residual | Stem Cell Transplantation | Multiple Myeloma - drug therapy | Time Factors | Polymerase Chain Reaction | Adult | Female | Boronic Acids - administration & dosage | Chemotherapy, Adjuvant | Multiple Myeloma - surgery | Bortezomib | Dexamethasone - administration & dosage | Kaplan-Meier Estimate | Treatment Outcome | Thalidomide - administration & dosage | Chi-Square Distribution | Disease-Free Survival | Multiple Myeloma - pathology | Tumor Burden - drug effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Gene Rearrangement | Italy | Aged | Multiple Myeloma - genetics | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Aspirin, Warfarin, or Enoxaparin Thromboprophylaxis in Patients With Multiple Myeloma Treated With Thalidomide: A Phase III, Open-Label, Randomized Trial
by Antonio Palumbo and Michele Cavo and Sara Bringhen and Elena Zamagni and Alessandra Romano and Francesca Patriarca and Davide Rossi and Fabiana Gentilini and Claudia Crippa and Monica Galli and Chiara Nozzoli and Roberto Ria and Roberto Marasca and Vittorio Montefusco and Luca Baldini and Francesca Elice and Vincenzo Callea and Stefano Pulini and Angelo M. Carella and Renato Zambello and Giulia Benevolo and Valeria Magarotto and Paola Tacchetti and Norbert Pescosta and Claudia Cellini and Claudia Polloni and Andrea Evangelista and Tommaso Caravita and Fortunato Morabito and Massimo Offidani and Patrizia Tosi and Mario Boccadoro
Journal of Clinical Oncology, ISSN 0732-183X, 03/2011, Volume 29, Issue 8, pp. 986 - 993
Purpose In patients with myeloma, thalidomide significantly improves outcomes but increases the risk of thromboembolic events. In this randomized, open-label,... 
LOW-DOSE WARFARIN | DEXAMETHASONE | THERAPY | VENOUS THROMBOEMBOLISM | ONCOLOGY | DEEP-VEIN THROMBOSIS | PREDNISONE PLUS THALIDOMIDE | BORTEZOMIB | STEM-CELL TRANSPLANTATION | ELDERLY-PATIENTS | MELPHALAN | Multiple Myeloma - mortality | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Warfarin - adverse effects | Male | Antineoplastic Agents - administration & dosage | Enoxaparin - therapeutic use | Enoxaparin - adverse effects | Warfarin - therapeutic use | Fibrinolytic Agents - adverse effects | Multiple Myeloma - drug therapy | Thromboembolism - prevention & control | Time Factors | Aspirin - adverse effects | Fibrinolytic Agents - therapeutic use | Cardiovascular Diseases - mortality | Female | Aspirin - therapeutic use | Platelet Aggregation Inhibitors - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Cardiovascular Diseases - etiology | Risk Assessment | Multiple Myeloma - complications | Risk Factors | Anticoagulants - therapeutic use | Treatment Outcome | Thromboembolism - etiology | Thromboembolism - mortality | Thalidomide - administration & dosage | Anticoagulants - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Italy | Aged | Hemorrhage - chemically induced | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Melphalan, Prednisone, and Lenalidomide Treatment for Newly Diagnosed Myeloma: A Report From the GIMEMA—Italian Multiple Myeloma Network
by Antonio Palumbo and Patrizia Falco and Paolo Corradini and Antonietta Falcone and Francesco Di Raimondo and Nicola Giuliani and Claudia Crippa and Giovannino Ciccone and Paola Omedè and Maria Teresa Ambrosini and Francesca Gay and Sara Bringhen and Pellegrino Musto and Robin Foà and Robert Knight and Jerome B. Zeldis and Mario Boccadoro and Maria Teresa Petrucci and GIMEMA--Italian Multiple Myeloma Network
Journal of Clinical Oncology, ISSN 0732-183X, 10/2007, Volume 25, Issue 28, pp. 4459 - 4465
Purpose Lenalidomide has shown significant antimyeloma activity in clinical studies. Oral melphalan, prednisone, and thalidomide have been regarded as the... 
SURVIVAL | THERAPY | ONCOLOGY | THALIDOMIDE | BORTEZOMIB | STEM-CELL TRANSPLANTATION | ELDERLY-PATIENTS | DERIVATIVES | HIGH-DOSE DEXAMETHASONE | CHEMOTHERAPY | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Thalidomide - pharmacology | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Dose-Response Relationship, Drug | Thalidomide - analogs & derivatives | Multiple Myeloma - drug therapy | Melphalan - adverse effects | Drug-Related Side Effects and Adverse Reactions | Female | Melphalan - pharmacology | Thalidomide - adverse effects | Prednisone - administration & dosage | Prednisone - adverse effects | Administration, Oral | Thalidomide - administration & dosage | Maximum Tolerated Dose | Melphalan - administration & dosage | Multiple Myeloma - pathology | Survival Analysis | Prednisone - pharmacology | Aged | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text "Delirium Day": A nationwide point prevalence study of delirium in older hospitalized patients using an easy standardized diagnostic tool
by Bellelli, Giuseppe and Morandi, Alessandro and Di Santo, Simona G and Mazzone, Andrea and Cherubini, Antonio and Mossello, Enrico and Bo, Mario and Bianchetti, Angelo and Rozzini, Renzo and Zanetti, Ermellina and Musicco, Massimo and Ferrari, Alberto and Ferrara, Nicola and Trabucchi, Marco and Boffelli, Stefano and Stefano, Fabio Di and Filippi, Francesco De and Guerini, Fabio and Bertoletti, Erik and March, Albert and Margiotta, Alessandro and Mecocci, Patrizia and Addesi, Desireè and Fantò, Fausto and Dijik, Babette and Porrino, Paola and Cotroneo, Antonino Maria and Galli, Giovanni and Bruni, Amalia Cecilia and Bernardini, Bruno and Corsini, Carla and Cagnin, Annachiara and Zurlo, Amedeo and Barbagallo, Giuseppe and Lunardelli, Maria Lia and Martini, Emilio and Battaglia, Giuseppe and Latella, Raffaele and Petritola, Donatella and Sinforiani, Elena and Cester, Alberto and Formilan, Marino and Carbone, Pasqualina and Appollonio, Ildebrando and Cereda, Diletta and Tremolizzo, Lucio and Bottacchi, Edo and Lucchetti, Lucio and Mariani, Claudio and Rapazzini, Piero and Romanelli, Giuseppe and Marengoni, Alessandra and Zuliani, Giovanni and Bianchi, Lara and Suardi, Teresa and Muti, Ettore and Bottura, Renato and Sgrò, Giovanni and Mandas, Antonella and Serchisu, Luca and Crippa, Patrizia and Ivaldi, Claudio and Ungar, Andrea and Villani, Daniele and Raimondi, Clara and Mussi, Chiara and Isaia, Giancarlo and Provenzano, Giuseppe and Mari, Daniela and Odetti, Patrizio and Monacelli, Fiammetta and Incalzi, Raffaele Antonelli and Pluderi, Alice and Bellamoli, Claudio and Terranova, Luciano and Scarpini, Elio and D'Amico, Ferdinando and Cavallini, Maria Chiara and Guerrini, Gianbattista and Scotuzzi, Anna Maria and Chiarello, Antonino and Pilotto, Alberto and Tognini, Sara and Dell'Aquila, Giuseppina and Toigo, Gabriele and Ceschia, Giuliano and Piccinini, Maristella and Fabbo, Andrea and Zoli, Marco and Forti, Paola and Wenter, Christian and Basile, Giorgio and Lasagni, Anna and Padovani, Alessandro and Rozzini, Luca and Cottino, Maria and Vitali, Silvia and Tripi, Gabriele and Avanzi, Stefano and Annoni, Giorgio and ... and Italian Study Grp Delirium ISGoD and Italian Study Group on Delirium (ISGoD)
BMC Medicine, ISSN 1741-7015, 07/2016, Volume 14, Issue 1, pp. 106 - 106
Background: To date, delirium prevalence in adult acute hospital populations has been estimated generally from pooled findings of single-center studies and/or... 
Delirium | Prevalence | Hospital | Multicenter | 4AT | MORTALITY | DEMENTIA | ASSOCIATIONS | QUALITATIVE EVALUATION | SYMPTOMS | HIP FRACTURE PATIENTS | CARE | MEDICINE, GENERAL & INTERNAL | ELDERLY MEDICAL INPATIENTS | POSTOPERATIVE DELIRIUM | PEOPLE | Delirium - epidemiology | Prospective Studies | Cross-Sectional Studies | Humans | Logistic Models | Male | Inpatients - statistics & numerical data | Aged, 80 and over | Female | Italy - epidemiology | Surveys and Questionnaires | Aged | Odds Ratio | Delirium - diagnosis | Psychological aspects | Aged patients | Statistics | Health aspects | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Bortezomib As Induction Before Autologous Transplantation, Followed by Lenalidomide As Consolidation-Maintenance in Untreated Multiple Myeloma Patients
by Antonio Palumbo and Francesca Gay and Patrizia Falco and Claudia Crippa and Vittorio Montefusco and Francesca Patriarca and Fausto Rossini and Simona Caltagirone and Giulia Benevolo and Norbert Pescosta and Tommasina Guglielmelli and Sara Bringhen and Massimo Offidani and Nicola Giuliani and Maria Teresa Petrucci and Pellegrino Musto and Anna Marina Liberati and Giuseppe Rossi and Paolo Corradini and Mario Boccadoro
Journal of Clinical Oncology, ISSN 0732-183X, 02/2010, Volume 28, Issue 5, pp. 800 - 807
Purpose To evaluate the effect of bortezomib as induction therapy before autologous transplantation, followed by lenalidomide as consolidation-maintenance in... 
PREDNISONE | THERAPY | PLUS DEXAMETHASONE | ONCOLOGY | NEWLY-DIAGNOSED MYELOMA | PHASE-II | THALIDOMIDE IMPROVES SURVIVAL | RANDOMIZED CONTROLLED-TRIAL | STEM-CELL TRANSPLANTATION | ELDERLY-PATIENTS | MELPHALAN | Multiple Myeloma - mortality | Humans | Middle Aged | Pyrazines - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Transplantation, Autologous | Stem Cell Transplantation | Thalidomide - analogs & derivatives | Multiple Myeloma - drug therapy | Time Factors | Doxorubicin - analogs & derivatives | Protease Inhibitors - administration & dosage | Female | Neoadjuvant Therapy | Boronic Acids - administration & dosage | Chemotherapy, Adjuvant | Multiple Myeloma - surgery | Doxorubicin - administration & dosage | Prednisone - administration & dosage | Bortezomib | Dexamethasone - administration & dosage | Kaplan-Meier Estimate | Treatment Outcome | Thalidomide - administration & dosage | Polyethylene Glycols - administration & dosage | Disease-Free Survival | Melphalan - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Italy - epidemiology | Aged | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Recurrence of hypertensive disorders of pregnancy: an individual patient data metaanalysis
by van Oostwaard, Miriam F., MD and Langenveld, Josje, MD, PhD and Schuit, Ewoud, MSc, PhD and Papatsonis, Dimitri N.M., MD, PhD and Brown, Mark A., MD, PhD and Byaruhanga, Romano N., MD, PhD and Bhattacharya, Sohinee, MD, PhD and Campbell, Doris M., MD, PhD and Chappell, Lucy C., MD, PhD and Chiaffarino, Francesca, ScD and Crippa, Isabella, MD, PhD and Facchinetti, Fabio, MD, PhD and Ferrazzani, Sergio, MD, PhD and Ferrazzi, Enrico, MD, PhD and Figueiró-Filho, Ernesto A., MD, PhD and Gaugler-Senden, Ingrid P.M., MD, PhD and Haavaldsen, Camilla, MD, PhD and Lykke, Jacob A., MD, PhD and Mbah, Alfred K., PhD and Oliveira, Vanessa M., MD, PhD and Poston, Lucilla, MD, PhD and Redman, Christopher W.G., MD, PhD and Salim, Raed, MD, PhD and Thilaganathan, Baskaran, MD, PhD and Vergani, Patrizia, MD, PhD and Zhang, Jun, MD, PhD and Steegers, Eric A.P., MD, PhD and Mol, Ben Willem J., MD, PhD and Ganzevoort, Wessel, MD, PhD
American Journal of Obstetrics and Gynecology, ISSN 0002-9378, 2015, Volume 212, Issue 5, pp. 624.e1 - 624.e17
Objective We performed an individual participant data (IPD) metaanalysis to calculate the recurrence risk of hypertensive disorders of pregnancy (HDP) and... 
Obstetrics and Gynecology | gestational hypertension | recurrence | preeclampsia | IPD | HELLP syndrome | pregnancy | IPD preeclampsia | HELLP | syndrome | Gestational hypertension | LONG-TERM PROGNOSIS | RETROSPECTIVE COHORT | RANDOMIZED-TRIAL | HELLP-SYNDROME HEMOLYSIS | ELEVATED LIVER-ENZYMES | OBSTETRICS & GYNECOLOGY | LOW-DOSE ASPIRIN | LOW PLATELETS | MOLECULAR-WEIGHT HEPARIN | 2ND PREGNANCY | Severity of Illness Index | HELLP Syndrome - drug therapy | Pre-Eclampsia - epidemiology | Recurrence | Humans | Anticonvulsants - therapeutic use | Postpartum Period | Antihypertensive Agents - therapeutic use | Premature Birth - epidemiology | Hypertension, Pregnancy-Induced - drug therapy | HELLP Syndrome - epidemiology | Pregnancy | Young Adult | Pre-Eclampsia - drug therapy | Hypertension, Pregnancy-Induced - epidemiology | Adult | Female | Infant, Small for Gestational Age | Hypertension - epidemiology | Chronic Disease | Infant, Newborn | Cohort Studies | Hypertension | Women | Pregnant women | Health aspects | Analysis | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text From Whole Gene Deletion to Point Mutations of EP300‐Positive Rubinstein–Taybi Patients: New Insights into the Mutational Spectrum and Peculiar Clinical Hallmarks
by Negri, Gloria and Magini, Pamela and Milani, Donatella and Colapietro, Patrizia and Rusconi, Daniela and Scarano, Emanuela and Bonati, Maria Teresa and Priolo, Manuela and Crippa, Milena and Mazzanti, Laura and Wischmeijer, Anita and Tamburrino, Federica and Pippucci, Tommaso and Finelli, Palma and Larizza, Lidia and Gervasini, Cristina
Human Mutation, ISSN 1059-7794, 02/2016, Volume 37, Issue 2, pp. 175 - 183
Rubinstein–Taybi syndrome (RSTS) is a rare congenital neurodevelopmental disorder characterized by growth deficiency, skeletal abnormalities, dysmorphic... 
genotype–phenotype correlation | EP300 | Rubinstein–Taybi syndrome | deletion | RSTS | Deletion | Genotype-phenotype correlation | Rubinstein-Taybi syndrome | PROTEIN | genotype-phenotype correlation | CREBBP MUTATIONS | PHENOTYPIC SPECTRUM | CBP | HETEROGENEITY | GENETICS & HEREDITY | PITUITARY | HATS | Gene Expression | Genetic Association Studies | Humans | E1A-Associated p300 Protein - genetics | Rubinstein-Taybi Syndrome - pathology | In Situ Hybridization, Fluorescence | Male | Sequence Analysis, DNA | CREB-Binding Protein - genetics | Genetic Variation | Young Adult | Phenotype | Rubinstein-Taybi Syndrome - genetics | Adolescent | Female | Mutation | Genome, Human | Child | Skin diseases | Genetic aspects | Genetic disorders | Gene mutations | Genes | Genotype & phenotype | Congenital diseases | Neurological disorders | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Ammonium nutrition as a strategy for cadmium mobilisation in the rhizosphere of sunflower
by Patrizia Zaccheo and Laura Crippa and Valeria Di Muzio Pasta
Plant and Soil, ISSN 0032-079X, 5/2006, Volume 283, Issue 1/2, pp. 43 - 56
Ammonium nutrition of higher plants results in rhizosphere acidification due to proton excretion by root cells. The acidification induced by ammonium-fed... 
Quaternary ammonium compounds | Agricultural soils | Plant roots | Plants | Acid soils | Soil pollution | Soil acidification | Silty soils | Sunflowers | Life Sciences | nitrogen fertilisers | cadmium | DMPP | phytoextraction | Ecology | Plant Physiology | Plant Sciences | sunflower | Soil Science & Conservation | rhizosphere acidification | Cadmium | Nitrogen fertilisers | Sunflower | Rhizosphere acidification | Phytoextraction | AGRONOMY | NITRATE | HEAVY-METALS | THLASPI-CAERULESCENS | PLANT SCIENCES | SOIL SCIENCE | PH CHANGES | CONTAMINATED SOILS | PHYTOREMEDIATION | PLANT-AVAILABILITY | ACCUMULATION | 3,4-DIMETHYLPYRAZOLE PHOSPHATE DMPP | Nutrition | Soils | Flowers & plants
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Investigation on Dabigatran Etexilate and Worsening of Renal Function in Patients with Atrial fibrillation: The IDEA Study
by Molteni, Mauro and Crippa, Matteo and Orenti, Annalisa and Polo Friz, Hernan and Menghini, Anna and Tramacere, Pierluigi and Marano, Giuseppe and Cimminiello, Claudio and Boracchi, Patrizia
Clinical Drug Investigation, ISSN 1173-2563, 4/2019, Volume 39, Issue 4, pp. 355 - 362
Warfarin-related nephropathy is an unexplained acute kidney injury, and may occur in patients with supratherapeutic INR, in the absence of overt bleeding.... 
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | K-DEPENDENT PROTEINS | STROKE | ACUTE KIDNEY INJURY | THERAPY | WARFARIN | ORAL ANTICOAGULANTS | RISK | PHARMACOLOGY & PHARMACY | HEMATURIA | THROMBIN INHIBITOR ASSAY | Dabigatran - pharmacology | Kidney - physiology | Kidney - drug effects | Prospective Studies | Follow-Up Studies | Atrial Fibrillation - drug therapy | Antithrombins - therapeutic use | Humans | Male | Atrial Fibrillation - physiopathology | Dabigatran - therapeutic use | Antithrombins - pharmacology | Kidney Function Tests - trends | Aged, 80 and over | Female | Aged | Atrial Fibrillation - diagnosis | Heart | Anticoagulants | Cardiac arrhythmia | Stroke | Kidneys | Laboratories | Patients | Generalized linear models | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights